Plain-English translation of NCT06425380 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a small pilot study testing resistant potato starch, a dietary supplement made from potato starch, in people who have cirrhosis (advanced liver scarring) and hepatic encephalopathy (a condition where liver damage causes confusion, memory loss, and brain fog). The researchers want to understand how this supplement affects the helpful bacteria in your gut and whether it might help reduce these brain-related symptoms.
Hepatic encephalopathy is a serious and distressing complication of advanced liver disease that affects thinking and memory. Current treatments exist, but doctors are looking for additional options—especially food-based approaches—that might work alongside or enhance existing care by improving gut health.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will take the resistant potato starch supplement daily for four weeks. During this time, researchers will collect information about your health and ask you to provide stool samples so they can study how the supplement affects your gut bacteria. The study is designed to be manageable and to fit into your regular routine while you continue any other treatments prescribed by your doctor.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States